These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38206209)
21. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B]. Wang XH; Liu XQ; Cai DC; Hu P; Li H Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024 [No Abstract] [Full Text] [Related]
22. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study. Zhang J; Du X; Zhou Z; Lv F; Yu Y J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226 [TBL] [Abstract][Full Text] [Related]
23. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads]. Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864 [TBL] [Abstract][Full Text] [Related]
24. Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT. Wang CC; Lim LY; Deubner H; Tapia K; Lau AW; Manansala J; Krows M; Shuhart MC; Kowdley KV J Clin Gastroenterol; 2008 Aug; 42(7):820-6. PubMed ID: 18458642 [TBL] [Abstract][Full Text] [Related]
25. Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B. McMahon BJ; Bulkow L; Simons B; Zhang Y; Negus S; Homan C; Spradling P; Teshale E; Lau D; Snowball M; Livingston SE Clin Gastroenterol Hepatol; 2014 Apr; 12(4):701-6.e1-3. PubMed ID: 24035774 [TBL] [Abstract][Full Text] [Related]
26. Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Chen EQ; Huang FJ; He LL; Bai L; Wang LC; Zhou TY; Lei XZ; Liu C; Tang H Dig Dis Sci; 2010 Feb; 55(2):432-7. PubMed ID: 19241166 [TBL] [Abstract][Full Text] [Related]
27. Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans. Hsu YN; Pan CQ; Abbasi A; Xia V; Bansal R; Hu KQ Dig Dis Sci; 2014 Apr; 59(4):865-71. PubMed ID: 24519522 [TBL] [Abstract][Full Text] [Related]
28. Liver histology of treatment-naïve children with chronic hepatitis B virus infection in Shanghai China. Hu Y; Wu X; Ye Y; Ye L; Han S; Wang X; Yu H Int J Infect Dis; 2022 Oct; 123():112-118. PubMed ID: 36028208 [TBL] [Abstract][Full Text] [Related]
29. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT]. Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151 [TBL] [Abstract][Full Text] [Related]
31. Clinical course of chronic hepatitis B (CHB) presented with normal ALT in Asian American patients. Nguyen K; Pan C; Xia V; Hu J; Hu KQ J Viral Hepat; 2015 Oct; 22(10):809-16. PubMed ID: 25611883 [TBL] [Abstract][Full Text] [Related]
32. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia. Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698 [TBL] [Abstract][Full Text] [Related]
33. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246 [TBL] [Abstract][Full Text] [Related]
34. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase. Tan Y; Ye Y; Zhou X; Chen L; Wen D PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705 [TBL] [Abstract][Full Text] [Related]
35. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone. Ren S; Wang W; Lu J; Wang K; Ma L; Zheng Y; Zheng S; Chen X Front Immunol; 2022; 13():1035923. PubMed ID: 36389814 [TBL] [Abstract][Full Text] [Related]
36. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China. Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183 [TBL] [Abstract][Full Text] [Related]
37. Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase. Gui HL; Wang H; Yang YH; Wu YW; Zhou HJ; Guo SM; Lin LY; Wang L; Cai W; Chen R; Guo Q; Zhou XQ; Bao SS; Xie Q J Viral Hepat; 2010 Mar; 17 Suppl 1():44-50. PubMed ID: 20586933 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study. Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283 [TBL] [Abstract][Full Text] [Related]
39. Treatment of chronic hepatitis B: case selection and duration of therapy. Leung N J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721 [TBL] [Abstract][Full Text] [Related]
40. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage]. You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]